Difference between revisions of "Lung Density Biomarker Ctte"

From QIBA Wiki
Jump to: navigation, search
(Groundwork Activities)
Line 10: Line 10:
 
:* Compare the sensitivity of CT measurements to spirometry and other accepted measures.   
 
:* Compare the sensitivity of CT measurements to spirometry and other accepted measures.   
 
:: This will be necessary in order to determine if Progressive Disease can be detected significantly sooner with quantitative imaging techniques than with currently accepted methods.
 
:: This will be necessary in order to determine if Progressive Disease can be detected significantly sooner with quantitative imaging techniques than with currently accepted methods.
 
 
 
==Project Snapshot==
 
  
  
 
==Profiling Activities==
 
==Profiling Activities==
Write Profile documents to which equipment and sites can conform to accomplish Quantification goals.
 
  
* [[What Are Profiles?]]
+
* [[Media:Profile_V0_1_Asthma_COPD.doc|COPD QIBA Profile v0.1]]
** [[Media:COPD_Profile_v1.0.doc|COPD Profile v1.0]]
+
* [[Media:Protocol_V0_1_Asthma_COPD.doc|COPD UPICT Protocol v0.1]]
  
 
*[[Media:Mr ODonnell QIBA Process Roadmap 20090629.ppt.pdf|Thoughts on the QIBA Process: Profiles, UPICT & Measurements by Kevin O’Donnell-20090629]]
 
*[[Media:Mr ODonnell QIBA Process Roadmap 20090629.ppt.pdf|Thoughts on the QIBA Process: Profiles, UPICT & Measurements by Kevin O’Donnell-20090629]]

Revision as of 00:45, 6 March 2011

This Wiki is for collaborative creation of QIBA's Chronic Obstructive Pulmonary Disease (COPD) and Asthma Committee materials and ongoing activities.


Mission: Reduce and characterize bias and variance across manufacturers, versions, and sites in support of quantitative CT lung densitometry and morphology.

Initial Objectives:

  • Characterize the precision and accuracy of phenotyping and progression measurements in emphysema and asthma.
This is an essential effort to classify phenotype and assess longitudinal changes as medically meaningful surrogates for health status.
  • Compare the sensitivity of CT measurements to spirometry and other accepted measures.
This will be necessary in order to determine if Progressive Disease can be detected significantly sooner with quantitative imaging techniques than with currently accepted methods.


Profiling Activities

Protocol Development Activities

Groundwork Activities

Validate key concepts and answer key questions needed to write the Profiles and demonstrate their effectiveness.

  • Phantom project

Meetings / Call Summaries


Working Documents


Reference Documents